We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
Surgerii Robotics: Single-Port Surgical Robots Poised to Transform Surgery
The worldwide surgical robotic market is expected to grow at a booming CAGR of 5.8% during 2022 to 2030, rising from USD 5.05 billion in 2022 to USD 21.41 billion in 2030. Of which, the single-port surgical robots that result in less pain, fewer scars, and quicker recovery, have tremendous up potential.
Mar 30, 2023 04:00 PM
ZD Medtech Raised Over CNY 100 Mn in Series B
Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn
2022 China AI Health 30 Report
Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A
Fine Vision Completes Angel Financing Round Worth Nearly CNY 50 Mn
YingHe Neuro Raises Over CNY 100 Mn in Angel Round
Equipment Company Keyto Nets Over CNY 100 Mn in Series C
HastenPharma Secures USD 315 Mn in Financing to Focus on M&A Business and R&D
Anhui-based biopharmaceutical company HastenPharma(海森生物) raised USD 315 million in funding on April 20, with the financing round aimed at focusing on future mergers and acquisitions and product innovation, according to EqualOcean.
Apr 23, 2023 12:20 PM
Artificial Cardiac Company CoretechMed Raises Nearly CNY 200 Mn in Series C+
In the past five years, China's ventricular assist technology (i.e., "artificial heart") has developed rapidly, and three domestic implantable ventricular assist devices (LVADs) have been approved and marketed by the State Drug Administration, and another one is in the marketing declaration stage. The number of LVAD implantations has increased yearly, with a total of 363 LVAD implantations performed in 70 hospitals, a rapid increase.
Apr 17, 2023 05:12 PM
IVD Company Bioantibody Nets Over CNY 100 Mn in Series A
Surgical Robot Platform Company KouTech Nets Over USD 10 Mn in Series A+ Round
F-star to be acquired by China biopharmaceutical with USD 161million
Clinical Microbiology Testing Company WillingMed Nets More than 100 Mn in Series B
WillingMed has independently developed and successfully reported and approved a series of automated testing instruments, software, testing reagents and other IVD products, and obtained intellectual property rights for more than 40 core technologies.
Apr 07, 2023 09:09 PM
20 Chinese Companies to Watch in Q1 2023– Healthcare+
Editor's note: We at EqualOcean tracked the major funding rounds or industry events that took place in China’s healthcare space in Q1 2023. The following is a list of deals that we have selected for you, based on a number of criteria, including the funding amount, the financial backers, the activity level and the segments in which the startups operate.
Apr 07, 2023 01:39 PM
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
Herui gene launched the early screening product "quansining" for multiple cancer types, covering six high-risk cancer types
East China medicine "liraglutide" goes to sea
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Interview With TI5 ROBOT: The Rise of the Robot Industry
May 18, 2023 10:38 AM
TOPS in Shanghai: The New Trends in the Pet Industry's Overseas Expansion
May 12, 2023 01:33 PM